Jorge DiMartino
Director/Board Member bei Gotham Therapeutics Corp.
Vermögen: 409 820 $ am 31.03.2024
Profil
Jorge DiMartino is currently a Director at Gotham Therapeutics Corp.
Prior to this, he was the Chief Medical Officer & EVP-Clinical Development at Kronos Bio, Inc. from 2019 to 2024.
Before that, he served as Vice President-Translational Development Oncology at Celgene Corp.
from 2014 to 2019.
He also worked as a Group Medical Director at Genentech, Inc. Additionally, he holds a doctorate degree from both the University of California San Diego and Cornell University Graduate School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
KRONOS BIO INC
0,52% | 04.01.2024 | 315 246 ( 0,52% ) | 409 820 $ | 31.03.2024 |
Aktive Positionen von Jorge DiMartino
Unternehmen | Position | Beginn |
---|---|---|
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jorge DiMartino
Unternehmen | Position | Ende |
---|---|---|
KRONOS BIO, INC. | Chief Tech/Sci/R&D Officer | 16.02.2024 |
CELGENE | Corporate Officer/Principal | 01.12.2019 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Jorge DiMartino
University of California San Diego | Doctorate Degree |
Cornell University Graduate School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KRONOS BIO, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Gotham Therapeutics Corp.
Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY. | Health Technology |